Search
NNZ-2591
go.drugbank.com/drugs/DB15601InvestigationalIt was granted Orphan Drug Designation by the FDA in October 2019[L11103] and was granted a patent by the European Patent Office in December 2019. … [L11100] Clinical trials are expected to begin in 2020.[L11103,L11100]
Sulfobutylether-beta-cyclodextrin
go.drugbank.com/drugs/DB18607ExperimentalCategories: Compounds used in a research, industrial, or household settingAcifluorfen
go.drugbank.com/drugs/DB07338ExperimentalAcifluorfen is a protoporphyrinogen oxidase inhibitor.
Categories: Compounds used in a research, industrial, or household setting4-Nitrophenyl Phosphate
go.drugbank.com/drugs/DB04214ExperimentalCategories: Compounds used in a research, industrial, or household settingEgtazic acid
go.drugbank.com/drugs/DB19986ExperimentalEgtazic acid is a small molecule drug. Egtazic acid has a monoisotopic molecular weight of 380.14 Da.
Categories: Compounds used in a research, industrial, or household settingDenopamine
go.drugbank.com/drugs/DB21277ExperimentalDenopamine is a small molecule drug. Denopamine has a monoisotopic molecular weight of 317.16 Da.
Categories: Compounds used in a research, industrial, or household settingTalactoferrin alfa
go.drugbank.com/drugs/DB05426InvestigationalLactoferrin, a protein found in breast milk is developed by Agennix.
Dilmapimod
go.drugbank.com/drugs/DB12140InvestigationalDilmapimod (SB-681323) is a p38 MAP-kinase inhibitor that has potential uses in inflammatory conditions such as RA (Rheumatoid Arthritis). … Previous p38 MAP-kinase inhibitors have been hindered in development by liver toxicity. Methotrexate (common treatment for RA patients) also has potential liver toxicity.}